Inuvo Inc (INUV) concluded trading on Wednesday at a closing price of $0.37, with 4.47 million shares of worth about $1.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 51.02% during that period and on December 18, 2024 the price saw a loss of about -3.60%. Currently the company’s common shares owned by public are about 140.47M shares, out of which, 114.70M shares are available for trading.
Stock saw a price change of 8.79% in past 5 days and over the past one month there was a price change of 80.31%. Year-to-date (YTD), INUV shares are showing a performance of -12.94% which increased to 10.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $0.57 during that period. The average intraday trading volume for Inuvo Inc shares is 825.55K. The stock is currently trading 17.57% above its 20-day simple moving average (SMA20), while that difference is up 38.51% for SMA50 and it goes to 25.60% higher than SMA200.
Inuvo Inc (AMEX: INUV) currently have 140.47M outstanding shares and institutions hold larger chunk of about 19.11% of that.
The stock has a current market capitalization of $51.98M and its 3Y-monthly beta is at 1.19. It has posted earnings per share of -$0.06 in the same period. It has Quick Ratio of 0.78 while making debt-to-equity ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INUV, volatility over the week remained 14.37% while standing at 15.06% over the month.
Stock’s fiscal year EPS is expected to rise by 45.83% while it is estimated to increase by 76.92% in next year. EPS is likely to grow at an annualized rate of 30.00% for next 5-years, compared to annual growth of 16.05% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Alliance Global Partners on July 28, 2020 offering a Buy rating for the stock and assigned a target price of $2.25 to it. On September 29, 2015, ROTH Capital Initiated their recommendations, while on May 19, 2015, H.C. Wainwright Initiated their ratings for the stock with a price target of $4.
